Magnetic Resonance Imaging in Critical Illness

ABPN Neurocritical Care Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neurologic Examination & Coma Assessment in the ICU

Current Examination, Blueprint & Preparation Neurologic Examination in Critically Ill Patients Coma Evaluation & Consciousness Alterations Delirium & Toxic-Metabolic Encephalopathy in the ICU

2 Chapter 2: Cerebral Physiology & Intracranial Dynamics

Cerebral Blood Flow, Metabolism & Autoregulation Intracranial Pressure & Compliance Cerebral Edema & Herniation Syndromes

3 Chapter 3: Intracranial Hypertension & Cerebral Perfusion Management

Tiered ICP Management Protocols Hyperosmolar Therapy & Fluid Management Advanced & Refractory ICP Interventions

4 Chapter 4: Airway, Mechanical Ventilation & Pulmonary ICU Management

Emergency Airway Management & Neuro-Intubation Mechanical Ventilation Strategies in Acute Brain Injury Tracheostomy & Ventilator Weaning in Neurocritical Care Pulmonary Complications in the Neuro-ICU Obstructive Lung Disease, Pulmonary Hypertension & Bronchoscopy

5 Chapter 5: Hemodynamics, Shock & Cardiovascular Management

Hemodynamic Monitoring & Blood Pressure Targets Vasoactive Agents: Inotropes, Vasopressors & Antihypertensives Cardiac Complications of Brain Injury

6 Chapter 6: Neuropharmacology, Analgesia & Sedation

ICU Sedation & Analgesia Neuromuscular Blockade & Monitoring Propofol Infusion Syndrome & Drug Toxicities Antiseizure Drug Pharmacology in the ICU

7 Bleeding, Thrombosis & Hematologic Emergencies

Warfarin & Heparin Reversal Direct Oral Anticoagulant (DOAC) Reversal Antiplatelet Management & Platelet Dysfunction Venous Thromboembolism Prophylaxis & Management Transfusion, Coagulopathy, TMA & Cellular-Therapy Neurotoxicity

8 Chapter 8: Systemic ICU Care, Fluids, Electrolytes & Endocrine

Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting Diabetes Insipidus, Hypernatremia & Endocrine Crises Critical Care Prophylaxis, Nutrition & Infection Prevention

9 Systemic Trauma & Environmental Injury

Polytrauma, Chest Injury & Abdominal Hemorrhage Burns, Electrical Injury & Hanging

10 Cardiac Emergencies & Mechanical Support

IABP, Ventricular Devices & ECMO Acute Coronary, Valvular, Rhythm & Aortic Emergencies

11 Kidney Injury, Acid–Base & Renal Replacement

Acute Kidney Injury & Renal Drug Clearance Acid–Base Disorders, Electrolytes & Renal Replacement

12 Systemic Infection & Endocrine Emergencies

Sepsis, Endocarditis & Antimicrobial Principles Thyroid, Adrenal & Dysglycemic Emergencies

13 Gastrointestinal & Hepatic Emergencies

Acute Abdomen, GI Bleeding & Abdominal Compartment Syndrome Acute Liver Failure, Cirrhosis & Hepatic Drug Effects

14 Chapter 9: Neuroimaging in the Neuro-ICU

Non-Contrast CT & CT Angiography CT Perfusion & Advanced Perfusion Imaging Magnetic Resonance Imaging in Critical Illness

15 Chapter 10: Electrophysiology & Neuromonitoring

Continuous EEG & ACNS Standardized Critical Care Terminology Invasive Neuromonitoring: ICP & External Ventricular Drains Multimodal Monitoring: PbtO2, Microdialysis & Transcranial Doppler

16 Angiography, Electrodiagnosis & CSF Analysis

Conventional Angiography & Cranial–Spinal Shunts EMG, Nerve Conduction & Acute Muscle Disease CSF Analysis: Infection, Inflammation & Hemorrhage

17 Chapter 11: Bedside Procedures, Ultrasound & Death by Neurologic Criteria

Critical Care Procedural Skills Critical Care Ultrasound & Echocardiography Determination of Death by Neurologic Criteria

18 Chapter 12: Acute Ischemic Stroke & Reperfusion Therapies

Acute Ischemic Stroke Management & Thrombolysis Endovascular Thrombectomy & Large Vessel Occlusion Malignant Hemispheric & Cerebellar Infarction

19 Chapter 13: Spontaneous Intracerebral Hemorrhage & Intraventricular Hemorrhage

Acute Intraparenchymal Hemorrhage Management Intraventricular Hemorrhage & Hydrocephalus Surgical Evacuation & Minimally Invasive Surgery in ICH

20 Chapter 14: Aneurysmal Subarachnoid Hemorrhage & Delayed Cerebral Ischemia

Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing Delayed Cerebral Ischemia & Cerebral Vasospasm Non-Aneurysmal Subarachnoid Hemorrhage & Vascular Malformations

21 Venous, Spinal & Traumatic Vascular Disease

Cerebral Venous Thrombosis & Spinal Cord Infarction Traumatic Dissection, Carotid–Cavernous Fistula & Penetrating Injury

22 Chapter 15: Traumatic Brain & Spinal Cord Injury

Severe Traumatic Brain Injury & Contusions Acute Traumatic Spinal Cord Injury & Neurogenic Shock Spine Trauma, Fractures & Cord Syndromes

23 Chapter 16: Status Epilepticus, Seizures & Neuromuscular Emergencies

Status Epilepticus: Convulsive & Non-Convulsive Refractory & Super-Refractory Status Epilepticus Acute Neuromuscular Respiratory Failure

24 Chapter 17: Post-Cardiac Arrest Care, CNS Infections & Encephalitis

Targeted Temperature Management & Post-Cardiac Arrest Care Post-Cardiac Arrest Neuroprognostication Acute CNS Infections, Encephalitis & Inflammatory Emergencies

25 Neuroinflammation & Neurooncology

Fulminant Demyelination & Autoimmune Encephalitis Brain, Spinal & Leptomeningeal Cancer Emergencies

26 Pregnancy, Transplantation & Pediatric Care

Pregnancy, Postpartum & Post-Transplant Neurologic Care Pediatric Neurocritical Care

27 Chapter 18: Neurosurgical & Perioperative Emergencies

Postoperative Neurosurgical Complications Device Complications: EVDs, Shunts & ICP Monitors Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies

28 Chapter 19: Ethics, Palliative Care & Organ Donation in the Neuro-ICU

Communication, Surrogate Decision-Making & Conflict Resolution Neuroprognostication Ethics, Withdrawal of Life Support & Palliative Care Organ Donation & Management of the Deceased Donor

Magnetic Resonance Imaging in Critical Illness

Key Takeaways Explain This Topic AI

DWI hyperintensity with reduced ADC supports restricted diffusion, with a differential including ischemia and other acute injuries.

DWI-FLAIR mismatch can support selected unknown-onset IVT eligibility but does not establish exact stroke onset.

SWI/GRE detects blood-related susceptibility patterns, while lesion distribution and clinical context determine the likely cause.

TOF MRA can show flow-related signal loss from slow or in-plane flow and can simulate stenosis or occlusion.

MRI transport requires physiologic stability planning, device and implant screening, and verified MR-safe or MR-conditional equipment.

Last updated: October 2026

Magnetic Resonance Imaging in Critical Illness

Magnetic Resonance Imaging (MRI) offers unparalleled soft-tissue resolution, multiparametric tissue characterization, and high sensitivity for hyperacute ischemic and inflammatory processes. However, deploying MRI in the neurocritical care unit requires balancing diagnostic precision against the significant physiological risks and logistical complexities of transporting unstable, monitored, and mechanically ventilated patients into high-magnetic-field environments.

Essential Neurocritical MRI Sequences

Modern neuro-ICU protocols leverage distinct pulse sequences that probe water diffusion, fluid suppression, magnetic susceptibility, and flow-related enhancement:

Sequence Physical / Biophysical Basis Core Clinical Neuro-ICU Indications Distinguishing Pathognomonic Patterns Common Pitfalls & Limitations

Diffusion-Weighted Imaging (DWI) Brownian motion of water molecules ( b = 1000 s/mm 2 b=1000\text{ s/mm}^2 b = 1000 s/mm 2 ) Hyperacute ischemia, encephalitis, abscess, cellular tumors Bright hyperintensity with corresponding low ADC values T2 shine-through (bright on DWI and bright on ADC)

Apparent Diffusion Coefficient (ADC) Quantitative mathematical calculation of water diffusivity Confirms cytotoxic edema; separates acute from chronic injury Quantitative dark hypointensity ( < 550 – 620 × 10 − 6 mm 2 / s <550\text{--}620 \times 10^{-6}\text{ mm}^2/\text{s} < 550 – 620 × 1 0 − 6 mm 2 / s ) Normalizes (pseudonormalization) at 7–14 days post-infarction

FLAIR T2-weighted with inversion pulse ( T I ≈ 2000 – 2500 ms TI \approx 2000\text{--}2500\text{ ms} T I ≈ 2000 – 2500 ms ) nulling CSF Subarachnoid hemorrhage, meningitis, contusions, MS Sulcal hyperintensity, periventricular plaques, edema CSF pulsation artifacts, incomplete CSF suppression with high FiO 2 \text{FiO}_2 FiO 2 ​

Gradient Echo (GRE) / SWI Phase-sensitive T2 ∗ \text{T2}^* T2 ∗ magnetic susceptibility blooming Microbleeds, cerebral amyloid angiopathy, DAI, CVST Blooming signal loss (hypointensity) from hemosiderin/deoxyhemoglobin Overestimates true lesion size; calcification mimics hemorrhage

TOF MRA / MRV Flow-related enhancement of unsaturated flowing spins Circle of Willis occlusions, aneurysms, dural sinus patency Intraluminal vascular reconstruction without gadolinium In-plane flow saturation mimics vessel stenosis or occlusion

Diffusion-Weighted Imaging (DWI) & Apparent Diffusion Coefficient (ADC)

DWI measures the microscopic translational Brownian motion of water. In healthy tissue, water moves freely within extracellular and intracellular compartments.

When acute arterial ischemia or profound cellular metabolic failure occurs:

Na + / K + \text{Na}^+/\text{K}^+ Na + / K + -ATPase pumps fail due to ATP depletion.

Sodium, chloride, and water rush into the intracellular compartment (cytotoxic edema).

The extracellular space shrinks, creating high tortuosity that severely restricts water diffusion .

This restricted diffusion is detected as bright signal hyperintensity on trace DWI within minutes of stroke onset.

Important

Differentiating Cytotoxic Edema from T2 Shine-Through: Trace DWI images contain inherent T2-weighting. Consequently, chronic cerebral lesions with prolonged T2 relaxation times (such as chronic encephalomalacia or vasogenic edema) can appear deceptively bright on trace DWI—a phenomenon known as T2 shine-through . To verify true acute cytotoxic edema, clinicians must inspect the quantitative Apparent Diffusion Coefficient (ADC) map:

True Restricted Diffusion (Cytotoxic Edema): Bright on DWI, Dark (hypointense) on ADC ( < 550 – 620 × 10 − 6 mm 2 / s <550\text{--}620 \times 10^{-6}\text{ mm}^2/\text{s} < 550 – 620 × 1 0 − 6 mm 2 / s ).

T2 Shine-Through (Vasogenic Edema / Chronic Lesion): Bright on DWI, Bright or Isointense on ADC.

T2 Blackout: Dark on DWI and dark on ADC (seen in acute hematomas containing intracellular methemoglobin).

Non-ischemic conditions presenting with acute restricted diffusion include:

Herpes Simplex Encephalitis (HSE): Asymmetric restricted diffusion and FLAIR hyperintensity in the medial temporal and inferior frontal lobes (limbic cortex).

Creutzfeldt-Jakob Disease (CJD): Confluent cortical restricted diffusion ("cortical ribboning") and asymmetric hyperintensity in the caudate, putamen, and posterior thalamus ("pulvinar" and "hockey-stick" signs).

Cerebral Abscess: The central necrotic cavity demonstrates homogeneous, intense restricted diffusion (high viscosity purulent fluid packed with neutrophils and bacteria), sharply differentiating it from the central non-restricted fluid of necrotic high-grade glioblastoma.

Fluid-Attenuated Inversion Recovery (FLAIR) & The WAKE-UP Paradigm

FLAIR utilizes an inversion recovery preparation pulse timed precisely to null the hyperintense T2 signal of cerebrospinal fluid ( C S F CSF CSF ). This renders parenchymal pathology abutting ventricles or sulci highly conspicuous.

Subarachnoid Hemorrhage & Meningitis: Blood, protein, or inflammatory exudate in the subarachnoid space prevents proper inversion nulling, producing striking sulcal FLAIR hyperintensity ("dirty CSF").

DWI-FLAIR Mismatch in Wake-Up Stroke:

Infarcted brain tissue takes approximately 4.0 – 4.5 hours 4.0\text{--}4.5\text{ hours} 4.0 – 4.5 hours to accumulate sufficient parenchymal free water to become visibly hyperintense on FLAIR sequences.

A positive hyperintense lesion on DWI that has no corresponding hyperintensity on FLAIR ("DWI-FLAIR mismatch") signifies that the stroke lesion is hyperacute and is more likely to be recent but cannot be timed exactly from the mismatch alone; selection protocols commonly use 4.5 hours 4.5\text{ hours} 4.5 hours .

The landmark WAKE-UP trial demonstrated that patients with wake-up strokes or unwitnessed onset who exhibit DWI-FLAIR mismatch benefit significantly from intravenous thrombolysis (alteplase), achieving superior 90-day functional recovery without excessive rates of symptomatic hemorrhage.

Susceptibility-Weighted Imaging (SWI) & Gradient Recalled Echo (GRE)

Paramagnetic substances—such as deoxyhemoglobin, methemoglobin, hemosiderin, and ferritin—distort the local homogeneous magnetic field, accelerating T2 ∗ \text{T2}^* T2 ∗ transverse dephasing. This causes profound signal drop-out with exaggerated spatial expansion, termed blooming artifact . SWI combines thin-slice 3D gradient-echo magnitude data with high-pass filtered phase data, yielding 3 to 6 times greater sensitivity than conventional GRE:

Diffuse Axonal Injury (DAI): Traumatic rotational acceleration shears fragile capillary beds running alongside axonal tracts. SWI detects punctate, petechial micro-hemorrhagic blooming lesions concentrated at three classic tiers of increasing injury severity:

Cortical gray-white matter junction (parasagittal frontal and temporal lobes).

Corpus callosum (especially the splenium).

Dorsolateral rostral brainstem (dorsolateral midbrain and upper pons).

Cerebral Amyloid Angiopathy (CAA): Characterized by multiple strictly lobar microbleeds, superficial cortical siderosis (cSS), and lobar macro-hemorrhages, with absence of deep hemorrhagic lesions required for the clinical Boston v2.0 categories; mixed small-vessel disease can coexist.

Cerebral Venous Sinus Thrombosis (CVST): SWI demonstrates the intravascular clot directly as blooming low signal within occluded cortical veins (the "cord sign" ) or within the lumen of the superior sagittal or transverse dural sinuses before recanalization.

Magnetic Resonance Angiography (MRA) & Venography (MRV)

Time-of-Flight (TOF) MRA: 3D TOF relies on the inflow of fully magnetized ("unsaturated") flowing blood into an imaging slice where stationary background tissue spins have been saturated by repeated RF pulses. It visualizes the circle of Willis and proximal intracranial vasculature without intravenous contrast.

Pitfall: When blood flows slowly, turbulently, or in-plane with the slice (e.g., within an aneurysm sac, distal to a tight stenosis, or in horizontal venous sinuses), spins become saturated, causing loss of signal that falsely mimics complete vascular occlusion. Contrast-enhanced MRA circumvents flow-related saturation.

Critical Care Safety, Monitoring & Transport to MRI

Transferring a critically ill neuro-ICU patient into the high-field MR environment presents severe hazards. The static magnetic field of a clinical MR scanner ( 1.5 T 1.5\text{T} 1.5 T or 3.0 T 3.0\text{T} 3.0 T ) is 30 , 000 to 60 , 000 30,000\text{ to }60,000 30 , 000 to 60 , 000 times stronger than the Earth’s magnetic field and is always active ("the magnet is always on").

ACR MRI Safety Zones

The American College of Radiology (ACR) establishes four concentric safety zones:

Zone I: Publicly accessible hospital corridors and waiting areas.

Zone II: Unrestricted patient intake, registration, and initial screening area under MR personnel supervision.

Zone III: Strictly restricted area directly outside the magnet room. Ferromagnetic objects entering Zone III pose lethal projectile risks if brought near the magnet. Access is rigorously controlled by trained MR staff.

Zone IV: The magnet room itself. Static magnetic fields and spatial gradients are maximal. Only rigorously screened, documented MR Safe or MR Conditional equipment may cross the threshold.

Ferromagnetic Hazards & Equipment Classification

MR Safe: An item that poses no known hazards resulting from exposure to any MR environment (e.g., non-conductive, non-magnetic plastic, silicone). Marked with a green square label.

MR Conditional: An item that has been demonstrated to pose no known hazards in a specified MR environment with specific conditions of use (static field strength, spatial field gradient, and specific absorption rate [SAR] limits). Marked with a yellow triangle label.

MR Unsafe: An item known to pose hazards in all MR environments (e.g., standard steel scissors, conventional oxygen tanks, standard ICU beds). Marked with a red circle with a slash.

Warning

Projectile Effect (Missile Effect): Ferromagnetic objects brought into Zone IV experience intense translational attraction, transforming into lethal ballistic projectiles. Standard ICU infusion poles, wrenches, and conventional gas cylinders have caused fatal injuries upon striking the scanner gantry. Never allow unverified equipment into Zone III or IV.

ICU Monitoring & Patient Stability During Transport

Adverse events occur in up to 30 % 30\% 30% of intrahospital critical care transports. Neurocritical patients are particularly susceptible to secondary brain injury caused by:

Hypoxia and Hypoventilation: Accidental extubation, ventilator dyssynchrony, or loss of positive end-expiratory pressure ( P E E P PEEP PEEP ).

Hemodynamic Lability: Arterial line disconnection, vasoactive infusion interruption, or systemic hypotension ( M A P < 65 – 80 mmHg MAP < 65\text{--}80\text{ mmHg} M A P < 65 – 80 mmHg ) compromising cerebral perfusion pressure ( C P P CPP CPP ).

Intracranial Pressure Spikes: Agitation, neck twisting obstructing internal jugular venous return, coughing against the endotracheal tube, or loss of head-of-bed elevation ( 30 ∘ 30^\circ 3 0 ∘ ).

To maintain safety during prolonged MR imaging:

Use dedicated MR-conditional transport ventilators and MR-conditional multi-channel infusion pumps . Alternatively, standard pumps can be placed outside Zone IV using extra-long IV extension tubing passed through specialized RF waveguide conduits in the shielding wall.

Fiberoptic MR-conditional pulse oximetry and ECG leads must be deployed without creating coiled conductor loops, which can induce severe radiofrequency (RF) electrical currents and second- or third-degree thermal skin burns.

Invasive arterial blood pressure lines and end-tidal CO 2 \text{CO}_2 CO 2 ​ monitoring must be maintained throughout the scan.

Clinical Decision: Emergent MRI vs. CT in the Neuro-ICU

Indications for Emergent MRI:

Suspected acute basilar artery occlusion or brainstem/cerebellar stroke where NCCT bone artifact obscures the posterior fossa.

Suspected acute spinal cord compression (epidural hematoma, cord transection, or epidural abscess).

Acute limbic encephalitis (e.g., HSV) or Creutzfeldt-Jakob Disease.

Cerebral venous thrombosis where non-contrast CT and CTV are equivocal.

Wake-up stroke when evaluating for DWI-FLAIR mismatch.

When CT / CTA is Preferred:

The patient is hemodynamically unstable, actively herniating, or requires immediate surgical decompression.

Unknown implant status (unscreened pacemakers, intracranial metallic aneurysm clips, metallic intraocular foreign bodies).

Rapid time-critical stroke revascularization where transport to MRI would delay thrombectomy or thrombolytic delivery.